- Home
- MRVI vs QNST Comparison
MRVI vs QNST Comparison
Compare MRVI & QNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRVI | QNST |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 896.7M |
| IPO Year | 2020 | 2009 |
Fundamental Metrics
Financial Performance| Metric | MRVI | QNST |
|---|---|---|
| Price | $7.72 | $19.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $4.13 | ★ $24.75 |
| AVG Volume (30 Days) | ★ 4.0M | 1.0M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 14.29 | ★ 1650.00 |
| EPS | N/A | ★ 1.40 |
| Revenue | $185,743,000.00 | ★ $282,140,000.00 |
| Revenue This Year | $12.54 | $18.59 |
| Revenue Next Year | $7.87 | $14.80 |
| P/E Ratio | ★ N/A | $13.50 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.29 | $10.29 |
| 52 Week High | $9.42 | $22.29 |
Technical Indicators
Market Signals| Indicator | MRVI | QNST |
|---|---|---|
| Relative Strength Index (RSI) | 60.70 | 53.28 |
| Support Level | $5.37 | $11.08 |
| Resistance Level | N/A | $21.23 |
| Average True Range (ATR) | 0.51 | 0.76 |
| MACD | 0.20 | -0.28 |
| Stochastic Oscillator | 63.37 | 14.83 |
Price Performance
Historical ComparisonAbout MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
About QNST QuinStreet Inc.
QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia. Geographically, it operates in United States and Internationally, of which maximum revenue is derived from United States.